Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1083653

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dermatology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on patient care of reforms to dermatology services at Northern Lincolnshire and Goole NHS Foundation Trust; and what plans his Department has to improve the effectiveness and availability of dermatology services throughout the UK.
tabling member constituency	Cleethorpes
tabling member printed	Martin Vickers
uin	229669
answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>No assessment has been made. The commissioning and configuration of dermatology services in England is a local matter. The local National Health Service is best placed to make decisions that ensure services meet the needs of resident populations in the most appropriate way. Health is a devolved matter, and as such, dermatology services in Wales, Scotland and Northern Ireland are a matter for the devolved administrations.</p><p> </p><p>The majority of patients with dermatological disorders are managed in primary and community care. Whilst some patients may be referred for outpatient care, data collection here is not mandated, and is therefore partial and incomplete. Furthermore, the data that is available reports episodes of care, which are not a count of patients, as the same patient may have multiple episodes of care for the same reason.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229670 question first answered 15/03/2019 12:23:13 answering member 4067 label Biography information for Steve Brine
tabling member	3957 label Biography information for Martin Vickers

1083654

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dermatology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many patients with (a) psoriasis, (b) atopic dermatitis and (c) hidradenitis suppurativa were seen by a dermatologist in 2018 in (i) Northern Lincolnshire and Goole NHS Foundation Trust and (ii) nationally.
tabling member constituency	Cleethorpes
tabling member printed	Martin Vickers
uin	229670
answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>No assessment has been made. The commissioning and configuration of dermatology services in England is a local matter. The local National Health Service is best placed to make decisions that ensure services meet the needs of resident populations in the most appropriate way. Health is a devolved matter, and as such, dermatology services in Wales, Scotland and Northern Ireland are a matter for the devolved administrations.</p><p> </p><p>The majority of patients with dermatological disorders are managed in primary and community care. Whilst some patients may be referred for outpatient care, data collection here is not mandated, and is therefore partial and incomplete. Furthermore, the data that is available reports episodes of care, which are not a count of patients, as the same patient may have multiple episodes of care for the same reason.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229669 question first answered 15/03/2019 12:23:13 answering member 4067 label Biography information for Steve Brine
tabling member	3957 label Biography information for Martin Vickers

1083656

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the savings accrued to the public purse by North Lincolnshire Care Commissioning Group as a result of the implementation of Yorkshire and Humber AHSN’s improved faecal calprotectin pathway for diagnosis of Inflammatory Bowel Disease; and if he will make a statement.
tabling member constituency	Cleethorpes
tabling member printed	Martin Vickers
uin	229672
answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>No estimate has been made. The National Institute for Health and Care Excellence (NICE) recommends faecal calprotectin testing as an option to help doctors distinguish between inflammatory bowel diseases (IBDs), such as Crohn’s disease and ulcerative colitis, and non-IBDs, such as irritable bowel syndrome.</p><p> </p><p>The NICE IBD Quality Standard states that general practitioners (GP) and GP practices should ensure that testing is offered and clinical commissioning groups should ensure the diagnostic services are in place to support this.</p><p> </p><p>NHS England has produced a consensus guidance document that supports implementation of the NICE guidance. Both the guidance and statement can be found at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/dg11/resources/endorsed-resource-the-use-of-faecal-calprotectin-in-primary-care-as-a-decision-diagnostic-for-inflammatory-bowel-disease-and-irritable-bowel-syndrome-4595859613" target="_blank">www.nice.org.uk/guidance/dg11/resources/endorsed-resource-the-use-of-faecal-calprotectin-in-primary-care-as-a-decision-diagnostic-for-inflammatory-bowel-disease-and-irritable-bowel-syndrome-4595859613</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/03/2019 13:37:36 answering member 4067 label Biography information for Steve Brine
tabling member	3957 label Biography information for Martin Vickers

1083713

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pain
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of assessment and management of chronic pain by (a) general practitioners, (b) nurses and (c) pharmacists.
tabling member constituency	Cleethorpes
tabling member printed	Martin Vickers
uin	229696
answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>The routine assessment and management of pain is a required competency of all healthcare professionals. Many patients with chronic pain can be successfully supported and managed through routine primary and secondary care pain management services. Approaches to treatment are not all pharmacological; education in self-management techniques to aid symptom control may also be appropriate for some patients.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is currently developing guidance on the assessment and management of chronic pain aimed at all settings in which National Health Service and local authority commissioned care is provided. The guidance is expected to be published on 19 August 2020. Guidance scope for the NICE clinical guidance document in development can be found via the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/gid-ng10069/documents/final-scope" target="_blank">www.nice.org.uk/guidance/gid-ng10069/documents/final-scope</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229697 question first answered 15/03/2019 12:29:35 answering member 4067 label Biography information for Steve Brine
tabling member	3957 label Biography information for Martin Vickers

1083714

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pain
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that general practitioners, nurses and pharmacists are competent in the routine assessment and management of chronic pain.
tabling member constituency	Cleethorpes
tabling member printed	Martin Vickers
uin	229697
answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>The routine assessment and management of pain is a required competency of all healthcare professionals. Many patients with chronic pain can be successfully supported and managed through routine primary and secondary care pain management services. Approaches to treatment are not all pharmacological; education in self-management techniques to aid symptom control may also be appropriate for some patients.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is currently developing guidance on the assessment and management of chronic pain aimed at all settings in which National Health Service and local authority commissioned care is provided. The guidance is expected to be published on 19 August 2020. Guidance scope for the NICE clinical guidance document in development can be found via the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/gid-ng10069/documents/final-scope" target="_blank">www.nice.org.uk/guidance/gid-ng10069/documents/final-scope</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229696 question first answered 15/03/2019 12:29:36 answering member 4067 label Biography information for Steve Brine
tabling member	3957 label Biography information for Martin Vickers

1083716

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Physiotherapy: Recruitment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the increase in the number of physiotherapists that will be working in primary care networks over the next three years; and what steps his Department is taking to achieve that increase.
tabling member constituency	Cleethorpes
tabling member printed	Martin Vickers
uin	229699
answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>The NHS Long Term Plan made a clear commitment to the future of general practice, with primary and community care set to receive at least £4.5 billion more in real terms a year by 2023/24, meaning spending on these services will grow faster than the rising National Health Service budget. Since the launch of the Long Term Plan, NHS England and the British Medical Association’s General Practitioners (GP) Committee have agreed a five-year GP (General Medical Services) contract framework from 2019/20. The new contract framework will be essential to deliver the ambitions set out in the NHS Long Term Plan through strong general practice services.</p><p> </p><p>The contract included funding for the new Additional Roles Reimbursement Scheme, in Primary Care Networks (PCNs). PCNs will be guaranteed funding for an up to estimated 20,000 additional staff by 2023/24. This funds new roles for which there is both credible supply and demand. The scheme will meet a recurrent 70% of the costs of additional clinical pharmacists, physician associates, first contact physiotherapists, and first contact community paramedics; and 100% of the costs of additional social prescribing link workers.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 229096 question first answered 15/03/2019 13:30:56 answering member 4067 label Biography information for Steve Brine
tabling member	3957 label Biography information for Martin Vickers